Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
These bacteria also happen to be the most dominant group in probiotic organisms known for their specific health benefits to humans
Maternal L-Carnitine had no significant impact on MnSOD, TOM20 and OXPHOS complexes
How semaglutide B12 dosing compares to tirzepatide If you are weighing your options between semaglutide with B12 and tirzepatide, the dosing structures are different enough to warrant a direct comparison
Being me (sciencey minded) I've done my own trials on myself with in-date and out-of-date ampoules and found no difference
Sample Weekly Schedule Here is what a typical week looks like on this stack: Monday through Friday: Morning: Topical GHK-Cu applied to face and any target areas after cleansing Any time of day: Injectable GHK-Cu 200 to 600 mcg (if using injectable form) Evening: Optional second topical GHK-Cu application One day per week (your chosen semaglutide day): Semaglutide injection at your usual time (different site from GHK-Cu) Continue GHK-Cu as normal Weekend (if using 5-day injectable schedule): Continue topical GHK-Cu Skip injectable GHK-Cu (some patients prefer a 5 days on, 2 days off schedule for convenience, though daily is also fine) Expanding the Stack Some patients choose to add additional compounds to this foundation
)
